Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Accelrys Reports World Class Customer Satisfaction for its Scientific Operating Platform

Published: Wednesday, October 04, 2006
Last Updated: Wednesday, October 04, 2006
Bookmark and Share
Discovery Studio 1.6 incorporates the platform, SciTegic Pipeline Pilot, for automation and extensibility.

Accelrys has announced that SciTegic, the platform and solutions division of Accelrys, has received the highest customer satisfaction ratings measured last year by independent customer research-based consultants, TNS Prognostics. 

Through extensive surveys of over 250 customers, the study concluded that the SciTegic Division had 99.1% satisfied customers and the highest customer loyalty scores seen by TNS last year.

The importance of overall product quality was confirmed by users of the SciTegic scientific operating platform with 77% of respondents citing the quality of the product as the leading reason for their favourable reference.

Discovery Studio® 1.6, the most recent version of Accelrys’ suite of life science modelling and simulation tools for lead discovery and optimisation includes the integration of the scientific operating platform.

The combination of Discovery Studio 1.6 and Pipeline Pilot provides the ability to create and manage computational protocols that capture and automate data processing routines.

"Our scientific operating platform is fundamental to the long term strategy of Accelrys," said Matt Hahn, PhD, founder of SciTegic and Accelrys Vice President of Platform Strategy and Technology.

"Receiving such high customer satisfaction results reaffirms that our technology and our solutions team provide immense value to our customers."

"Accelrys is leveraging the relationships that SciTegic has had with customers and this customer-centric focus is essential to our continued success."

"As the leading provider of scientific software and service solutions, we're honoured to be recognised for delivering excellence in customer satisfaction."

Other Accelrys solutions incorporate the scientific operating platform. The extensive customisation capabilities of the platform allow both Accelrys and end users to create and deploy domain-tailored applications.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ALMA Welcomes Accelrys as a Premium Sponsor
Association of Lab Managers (ALMA) now supported by leading lab software provider Accelrys
Friday, April 04, 2014
Dassault Systèmes and Accelrys to Join Forces
Delivering Scientific Innovation in the Age of Experience
Friday, January 31, 2014
Accelrys Acquires QUMAS
The acquisition extends Accelrys’ informatics portfolio with the addition of mission-critical, end-to-end document and process management compliance solutions.
Tuesday, December 10, 2013
Accelrys Advances Biology Innovation with New Release of Assay and Study Management Product Suite
Accelrys BioRails 4.5 and Accelrys Morphit 3.0 accelerate assay pipelines, improve cascade management and enhance collaborative decision-making in discovery biology.
Tuesday, November 19, 2013
Accelrys Receives Highest Rating in Gartner's Latest Laboratory Informatics System Report
Accelrys was the only vendor to achieve the highest possible rating in all five categories of new product development (NPD)
Friday, October 11, 2013
Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software
Cambridge Isotope Laboratories, Inc. is deploying the Accelrys Laboratory Execution System (LES) and three applications within the Accelrys Laboratory Information Management System.
Tuesday, September 10, 2013
Accelrys Acquires Environmental Health and Safety Leader ChemSW
Chemical inventory management solutions improve compliance and sustainability impact of Accelrys’ Scientific Innovation Lifecycle Management portfolio
Wednesday, September 04, 2013
Cambridge Isotope Laboratories Selects Accelrys Lab Automation Software
Enterprise implementation follows successful pilot that achieved a 78 percent reduction in data review times and a 40 percent overall improvement in lab processing time
Sunday, September 01, 2013
The Evolution of the Integrated Platform: Accelrys' One-Two Punch
A look at how Accelrys is delivering an integrated platform of enterprise laboratory solutions.
Sunday, June 02, 2013
Accelrys and eMolecules Collaborate to Enhance Accelrys Available Chemicals Directory
Validated and curated in-stock compounds from eMolecules now accessible through Accelrys ACD
Saturday, April 06, 2013
Accelrys' Electronic Laboratory Notebooks Recognized in Gartner's Enterprise Category
Accelrys' electronic laboratory notebooks (ELN) as "very high" or "high" in each scientific and functional domain in a recent report by Gartner, Inc.
Sunday, March 03, 2013
Accelrys® ELN Delivers Seamless Integration with the Reaxys® Workflow Solution
New chemistry information management possibilities for research scientists arising from Accelrys' cooperation with Elsevier.
Sunday, March 03, 2013
Accelrys, Inc. Acquires Vialis AG
Accelrys Strengthens Leadership Position in Laboratory Informatics Market
Sunday, February 10, 2013
Accelrys Acquires Systems Integrator Vialis
Accelrys has acquired Vialis AG to solidify its market leadership in the laboratory informatics space
Sunday, January 20, 2013
German Cancer Research Center Selects Contur ELN from Accelrys
The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) has licensed the server-based, on-premises version of Accelrys' Contur Electronic Lab Notebook (ELN).
Friday, December 28, 2012
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos